These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
9. Co-occurring Wilson's disease and non-penicillamine-induced systematic lupus erythematosus: a case report and literature review. Shi W; Huang X; Zhang S; Jiao Y Clin Rheumatol; 2021 Jun; 40(6):2485-2490. PubMed ID: 33057918 [TBL] [Abstract][Full Text] [Related]
10. Early onset of nephrotic syndrome after treatment with D-penicillamine in a patient with Wilson's disease. Siafakas CG; Jonas MM; Alexander S; Herrin J; Furuta GT Am J Gastroenterol; 1998 Dec; 93(12):2544-6. PubMed ID: 9860423 [TBL] [Abstract][Full Text] [Related]
11. Hypothyroidism and dyshormonogenesis induced by D-penicillamine in children with Wilson's disease and healthy infants born to a mother with Wilson's disease. Hanukoglu A; Curiel B; Berkowitz D; Levine A; Sack J; Lorberboym M J Pediatr; 2008 Dec; 153(6):864-6. PubMed ID: 19014823 [TBL] [Abstract][Full Text] [Related]
12. [Nephrotic syndrome after treatment with penicillamine in Wilson's disease]. Hampel R; Meng W; Kallwellis G Z Gesamte Inn Med; 1976 Jul; 31(13):507-11. PubMed ID: 960872 [TBL] [Abstract][Full Text] [Related]
13. [Lupoid syndrome due to D-penicillamine associated with Wilson's disease: clinical study of a case]. Caille B; Harpey JP; Lejeune C; Sudre Y; Turpin R Ann Med Interne (Paris); 1971 Feb; 122(2):255-60. PubMed ID: 5579427 [No Abstract] [Full Text] [Related]
14. Wilson's disease with reversible renal tubular dysfunction. Correlation with proximal tubular ultrastructure. Elsas LJ; Hayslett JP; Spargo BH; Durant JL; Rosenberg LE Ann Intern Med; 1971 Sep; 75(3):427-33. PubMed ID: 5315082 [No Abstract] [Full Text] [Related]
15. [Penicillamine and other therapeutic methods in the treatment of Wilson's disease]. Czlonkowska A; Czlonkowski A Neurol Neurochir Pol; 1975; 9(3):401-6. PubMed ID: 1097955 [No Abstract] [Full Text] [Related]